https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
Brain metastasis quantity may be a negative prognostic factor for patients requiring resection of at least one lesion. We retrospectively reviewed patients who underwent surgical resection of brain metastases from July 2018 to June 2019 at our institution, and examined outcomes including overall survival (OS), progression free survival (PFS), and rates of local failure (LF). Patients were grouped according to the number of metastases at the time of surgery (single vs multiple). We identified 130 patients who underwent surgical
Like
Comment
Share
